(Q37990037)

English

Drug delivery in multiple indication (multipurpose) prevention technologies: systems to prevent HIV-1 transmission and unintended pregnancies or HSV-2 transmission

scientific article published on 02 March 2012

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

26 August 2017

Drug delivery in multiple indication (multipurpose) prevention technologies: systems to prevent HIV-1 transmission and unintended pregnancies or HSV-2 transmission (English)

1 reference

Europe PubMed Central

PubMed publication ID

26 August 2017

HIV transmission

0 references

prevention of HIV/AIDS

0 references

1 reference

based on heuristic

inferred from title

Human herpesvirus 2

1 reference

based on heuristic

inferred from title

author name string

David R Friend

1

1 reference

Europe PubMed Central

PubMed publication ID

26 August 2017

language of work or name

0 references

publication date

2 March 2012

1 reference

Europe PubMed Central

PubMed publication ID

26 August 2017

Expert Opinion on Drug Delivery

1 reference

Europe PubMed Central

PubMed publication ID

26 August 2017

9

1 reference

Europe PubMed Central

PubMed publication ID

26 August 2017

4

1 reference

Europe PubMed Central

PubMed publication ID

26 August 2017

417-427

1 reference

Europe PubMed Central

PubMed publication ID

26 August 2017

Combining prevention of HIV-1, other sexually transmitted infections and unintended pregnancies: Development of dual-protection technologies

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.668183

21 January 2018

Multipurpose prevention technologies: biomedical tools to prevent HIV-1, HSV-2, and unintended pregnancies

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.668183

21 January 2018

Effectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in women

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.668183

21 January 2018

Efficacy of contraceptive methods: A review of the literature

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.668183

21 January 2018

Dual Protection Against Unintended Pregnancy and Sexually Transmitted Infections

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.668183

21 January 2018

Choice is empowering: Getting strategic about preventing HIV infection in women

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.668183

21 January 2018

Dual protection: more needed than practised or understood

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.668183

21 January 2018

Preventing sexually transmitted infections and unintended pregnancy, and safeguarding fertility: triple protection needs of young women.

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.668183

21 January 2018

Dual action microbicides: reappraisal of their roles in contraceptive research

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.668183

21 January 2018

Spermicides, Microbicides and Antiviral Agents: Recent Advances in the Development of Novel Multi-Functional Compounds

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.668183

21 January 2018

Exploring novel approaches to vaginal drug delivery

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.668183

21 January 2018

Vaginal gel drug delivery systems: understanding rheological characteristics and performance.

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.668183

21 January 2018

Novel approaches to vaginal delivery and safety of microbicides: biopharmaceuticals, nanoparticles, and vaccines

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.668183

21 January 2018

Advances in development, scale-up and manufacturing of microbicide gels, films, and tablets

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.668183

21 January 2018

Microbicide delivery: formulation technologies and strategies.

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.668183

21 January 2018

Pharmaceutical development of microbicide drug products

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.668183

21 January 2018

Delivery of microbicides to the vagina: difficulties reported with the use of three devices, adherence to use and preferences.

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.668183

21 January 2018

Acceptability of vaginal film, soft-gel capsule, and tablet as potential microbicide delivery methods among African women

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.668183

21 January 2018

Adherence and its measurement in phase 2/3 microbicide trials

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.668183

21 January 2018

Promoting continuous use as a strategy for achieving adherence in a trial of the diaphragm with candidate microbicide

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.668183

21 January 2018

Advances in microbicide vaginal rings

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.668183

21 January 2018

Is the vagina an adequate route for the administration of hormonal contraceptives?

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.668183

21 January 2018

Family planning: the unfinished agenda

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.668183

21 January 2018

Low-dose intravaginal estradiol delivery using a Silastic vaginal ring for estrogen replacement therapy in postmenopausal women: a review

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.668183

21 January 2018

In vitro release properties of etonogestrel and ethinyl estradiol from a contraceptive vaginal ring

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.668183

21 January 2018

Comparison of ethinylestradiol pharmacokinetics in three hormonal contraceptive formulations: the vaginal ring, the transdermal patch and an oral contraceptive

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.668183

21 January 2018

Efficacy, acceptability and tolerability of the combined contraceptive ring, NuvaRing, compared with an oral contraceptive containing 30 microg of ethinyl estradiol and 3 mg of drospirenone.

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.668183

21 January 2018

The combined contraceptive vaginal ring, NuvaRing: an international study of user acceptability

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.668183

21 January 2018

Examining the efficacy, safety, and patient acceptability of the combined contraceptive vaginal ring (NuvaRing).

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.668183

21 January 2018

Extended use of a progesterone-releasing vaginal ring in nursing women: a phase II clinical trial

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.668183

21 January 2018

Long-term, controlled release of the HIV microbicide TMC120 from silicone elastomer vaginal rings.

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.668183

21 January 2018

Intravaginal ring delivery of the reverse transcriptase inhibitor TMC 120 as an HIV microbicide.

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.668183

21 January 2018

In vitro evaluation of nonnucleoside reverse transcriptase inhibitors UC-781 and TMC120-R147681 as human immunodeficiency virus microbicides

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.668183

21 January 2018

Pharmacokinetics of 2 dapivirine vaginal microbicide gels and their safety vs. Hydroxyethyl cellulose-based universal placebo gel.

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.668183

21 January 2018

Biostability of polyurethane elastomers: a critical review

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.668183

21 January 2018

A hot-melt extruded intravaginal ring for the sustained delivery of the antiretroviral microbicide UC781.

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.668183

21 January 2018

Polyurethane intravaginal ring for controlled delivery of dapivirine, a nonnucleoside reverse transcriptase inhibitor of HIV-1.

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.668183

21 January 2018

Segmented polyurethane intravaginal rings for the sustained combined delivery of antiretroviral agents dapivirine and tenofovir

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.668183

21 January 2018

Drug concentrations after topical and oral antiretroviral pre-exposure prophylaxis: implications for HIV prevention in women

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.668183

21 January 2018

Effect of aciclovir on HIV-1 acquisition in herpes simplex virus 2 seropositive women and men who have sex with men: a randomised, double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.668183

21 January 2018

Acyclovir and transmission of HIV-1 from persons infected with HIV-1 and HSV-2.

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.668183

21 January 2018

Persistence of HIV-1 receptor-positive cells after HSV-2 reactivation is a potential mechanism for increased HIV-1 acquisition

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.668183

21 January 2018

Human immunodeficiency virus type 1 (HIV-1) and herpes simplex virus type 2 (HSV-2) can coinfect and simultaneously replicate in the same human CD4+ cell: effect of coinfection on infectious HSV-2 and HIV-1 replication

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.668183

21 January 2018

Post-transcriptional transactivation of human retroviral envelope glycoprotein expression by herpes simplex virus Us11 protein

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.668183

21 January 2018

Co-infection and synergy of human immunodeficiency virus-1 and herpes simplex virus-1.

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.668183

21 January 2018

Frequency of symptomatic and asymptomatic herpes simplex virus type 2 reactivations among human immunodeficiency virus-infected men.

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.668183

21 January 2018

Interactions between herpes simplex virus type 2 and human immunodeficiency virus type 1 infection in African women: opportunities for intervention

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.668183

21 January 2018

Valacyclovir and acyclovir for suppression of shedding of herpes simplex virus in the genital tract

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.668183

21 January 2018

Topical tenofovir, a microbicide effective against HIV, inhibits herpes simplex virus-2 replication

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.668183

21 January 2018

Simultaneous delivery of tenofovir and acyclovir via an intravaginal ring

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.668183

21 January 2018

Couples' acceptability of the SILCS diaphragm for microbicide delivery

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.668183

21 January 2018

Rational design of HIV vaccine and microbicides: report of the EUROPRISE annual conference

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.668183

21 January 2018

Controlled release of antibodies for long-term topical passive immunoprotection of female mice against genital herpes

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.668183

21 January 2018

Anti-glycoprotein D antibodies that permit adsorption but block infection by herpes simplex virus 1 prevent virion-cell fusion at the cell surface

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.668183

21 January 2018

Sustained release of proteins from a modified vaginal ring device.

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.668183

21 January 2018

pH-responsive nanoparticles releasing tenofovir intended for the prevention of HIV transmission

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.668183

21 January 2018

Formulation of tenofovir-loaded functionalized solid lipid nanoparticles intended for HIV prevention

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.668183

21 January 2018

A new vaginal delivery system of amphotericin B: a dispersion of cationic liposomes in a thermosensitive gel.

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.668183

21 January 2018

Increased COX-2 expression in human vaginal epithelial cells exposed to nonoxynol-9, a vaginal contraceptive microbicide that failed to protect women from HIV-1 infection

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.668183

21 January 2018

Effectiveness of COL-1492, a nonoxynol-9 vaginal gel, on HIV-1 transmission in female sex workers: a randomised controlled trial

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.668183

21 January 2018

Clinical microbicide research: an overview

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.668183

21 January 2018

Design and in vitro evaluation of a novel bioadhesive vaginal drug delivery system for clindamycin phosphate

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.668183

21 January 2018

Hormonal contraception and HIV-1 transmission

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.668183

21 January 2018

In Vitro Evaluation of Mucoadhesive Vaginal Tablets of Antifungal Drugs Prepared with Thiolated Polymer and Development of a New Dissolution Technique for Vaginal Formulations

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.668183

21 January 2018

Pharmacokinetic Assessment of Dapivirine Vaginal Microbicide Gel in Healthy, HIV-Negative Women

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.668183

21 January 2018

Identifiers

10.1517/17425247.2012.668183

1 reference

Europe PubMed Central

PubMed publication ID

26 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

26 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37990037&oldid=1736383543"